Aspero Medical announces patent award for their micro-texturing Pillar technology designed to improve outcomes of endoscopy procedures
17 août 2021 10h46 HE | Innosphere Ventures
Boulder, Colorado, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Aspero Medical, a medical device startup company developing new products for the field of gastroenterology, announced that the United States...
Metacrine-Logo-R Transparent.png.png
Metacrine Appoints Dr. Julia C. Owens to Its Board of Directors
05 avr. 2021 16h05 HE | Metacrine, Inc.
SAN DIEGO, April 05, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and...
Aspero Medical completes animal clinical study and announces the formation of Clinical Advisory Board
29 déc. 2020 10h24 HE | Innosphere Ventures
Boulder, Colorado, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Aspero Medical, a medical device startup focused on developing new products for the field of gastroenterology recently completed the company’s...
Aspero Medical receives $225,000 Grant for development of intraoperative gastrointestinal endoscopic balloon overtube
18 août 2020 11h27 HE | Innosphere
Boulder, Colorado, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Aspero Medical, a medical device startup focused on developing solutions and applications for the field of gastroenterology, has received a...
Metacrine-Logo-R.jpg
Metacrine to Present at Jefferies 2019 London Healthcare Conference
18 nov. 2019 07h30 HE | Metacrine, Inc.
SAN DIEGO, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and...
Aspero Medical announces James Willett as CEO
19 sept. 2019 17h26 HE | Innosphere
Boulder, Colorado, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Aspero Medical, University of Colorado Boulder spinoff and Innosphere client company, announced today that James Willett has been appointed...
Metacrine-Logo-R.jpg
Metacrine Secures $50 Million Growth Capital Facility from K2 HealthVentures
18 sept. 2019 07h30 HE | Metacrine, Inc.
SAN DIEGO, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and...
Aspero Medical Receives Seed Round Investment from Innosphere Fund
04 sept. 2019 15h36 HE | Innosphere Fund
Colorado, Sept. 04, 2019 (GLOBE NEWSWIRE) -- The Innosphere Fund, a seed-stage venture fund that was formed to accelerate the growth and exit of Innosphere client companies, announced their second...
Metacrine-Logo-R.jpg
Metacrine Doses First Patient in 12-Week NASH Proof-of-Concept Trial with a Sustained FXR Agonist
09 juil. 2019 07h30 HE | Metacrine, Inc.
SAN DIEGO, July 09, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and...
Metacrine-Logo-R.jpg
Metacrine Reports Positive Interim Results with Sustained FXR Agonist in NASH Patients
29 mai 2019 07h30 HE | Metacrine, Inc.
SAN DIEGO, May 29, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and...